Medical research

Ivermectin does not prevent progression to severe COVID-19

Ivermectin treatment during early illness does not prevent progression to severe disease for high-risk patients with mild-to-moderate COVID-19, according to a study published online Feb. 18 in JAMA Internal Medicine.

Cardiology

What women should know about their heart health

Heart disease and stroke continue to be the most dangerous threats to a woman's health. In the U.S., 1 in 4 women die from cardiovascular disease. During February, which is American Heart Month, there continues to be an emphasis ...

Medications

What are the risks and benefits of low-dose aspirin?

Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology.

page 21 from 40